These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

37 related articles for article (PubMed ID: 11457435)

  • 21. From genetics to pathology: tau and alpha-synuclein assemblies in neurodegenerative diseases.
    Goedert M; Spillantini MG; Serpell LC; Berriman J; Smith MJ; Jakes R; Crowther RA
    Philos Trans R Soc Lond B Biol Sci; 2001 Feb; 356(1406):213-27. PubMed ID: 11260802
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathogenic effects of alpha-synuclein aggregation.
    Lundvig D; Lindersson E; Jensen PH
    Brain Res Mol Brain Res; 2005 Mar; 134(1):3-17. PubMed ID: 15790525
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alpha-synuclein and transgenic mouse models.
    Fernagut PO; Chesselet MF
    Neurobiol Dis; 2004 Nov; 17(2):123-30. PubMed ID: 15474350
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alpha-synuclein and neurodegenerative diseases.
    Goedert M
    Nat Rev Neurosci; 2001 Jul; 2(7):492-501. PubMed ID: 11433374
    [No Abstract]   [Full Text] [Related]  

  • 25. [Analysis of alpha-synuclein and its significance].
    Nonaka T; Iwatsubo T; Hasegawa M
    Nihon Rinsho; 2004 Sep; 62(9):1623-8. PubMed ID: 15462375
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanisms of neurodegenerative disorders: Part 1: protein aggregates.
    Wolozin B; Behl C
    Arch Neurol; 2000 Jun; 57(6):793-6. PubMed ID: 10867775
    [No Abstract]   [Full Text] [Related]  

  • 27. Neurodegenerative diseases caused by protein aggregation: a phenomenon at the borderline between molecular evolution and ageing.
    Stoppini M; Andreola A; Foresti G; Bellotti V
    Pharmacol Res; 2004 Oct; 50(4):419-31. PubMed ID: 15304239
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intracellular Thermometry at the Micro-/Nanoscale and its Potential Application to Study Protein Aggregation Related to Neurodegenerative Diseases.
    Chung CW; Kaminski Schierle GS
    Chembiochem; 2021 May; 22(9):1546-1558. PubMed ID: 33326160
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiple ligand interaction of alpha-synuclein produced various forms of protein aggregates in the presence of Abeta25-35, copper, and eosin.
    Kim YS; Lee D; Lee EK; Sung JY; Chung KC; Kim J; Paik SR
    Brain Res; 2001 Jul; 908(1):93-8. PubMed ID: 11457435
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alpha-synuclein: its biological function and role in neurodegenerative diseases.
    Kaplan B; Ratner V; Haas E
    J Mol Neurosci; 2003 Apr; 20(2):83-92. PubMed ID: 12794302
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Review: formation and properties of amyloid-like fibrils derived from alpha-synuclein and related proteins.
    El-Agnaf OM; Irvine GB
    J Struct Biol; 2000 Jun; 130(2-3):300-9. PubMed ID: 10940234
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insights into the thermodynamics of copper association with amyloid-β, α-synuclein and prion proteins.
    Hong L; Simon JD
    Metallomics; 2011 Mar; 3(3):262-6. PubMed ID: 21116546
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Following the leader: fibrillization of alpha-synuclein and tau.
    Frasier M; Wolozin B
    Exp Neurol; 2004 Jun; 187(2):235-9. PubMed ID: 15144849
    [No Abstract]   [Full Text] [Related]  

  • 34. A protein-chameleon: conformational plasticity of alpha-synuclein, a disordered protein involved in neurodegenerative disorders.
    Uversky VN
    J Biomol Struct Dyn; 2003 Oct; 21(2):211-34. PubMed ID: 12956606
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.